Previous Article | Next Article ![]()
Infection and Immunity, June 2000, p. 3787-3791, Vol. 68, No. 6
Division of Infectious Diseases, Department
of Medicine, Santa Clara Valley Medical Center, and California
Institute for Medical Research, San Jose,1 and
Stanford University School of Medicine,
Stanford,2 California
Received 13 December 1999/Returned for modification 27 January
2000/Accepted 19 March 2000
Human serum at low concentrations inhibits the growth of
Cryptococcus neoformans in vitro. Fractionation of serum
yielded a purified inhibitory protein with a molecular mass of ~81.8
kDa, a pI of ~6.2, and an amino acid sequence that matched that of human transferrin. The inhibitory activity and that of apotransferrin and 5% human serum were reversed by 10 µM freshly prepared
FeCl3.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of an Anticryptococcal Protein
Isolated from Human Serum
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, 751 South Bascom Ave., San Jose, CA 95128-2699. Phone: (408)
885-4313. Fax: (408) 885-4306. E-mail:
stevens{at}leland.stanford.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»